UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Arbutus Biopharma is implementing good security practices.
Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.
This report shows a preliminary security rating for Arbutus Biopharma. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
A cyber attack (or cyberattack) is any attempt to expose, alter, disable, destroy, steal or gain ...
Vendor risk management (VRM) deals with the management and monitoring of risks resulting from ...
Compare Arbutus Biopharma's security performance with other companies